World's First Observational Trial to Assess Real-World

PharmAla partners with Heroic Hearts Canada and the University of Calgary to launch the world's first observational rial into MDMA's real-world efficacy...

Related Keywords

Vancouver ,British Columbia ,Canada ,United Kingdom ,Calgary ,Alberta ,British ,Canadian ,Nick Kadysh ,Kaitlin Ogrady ,David Fascinato ,Eleah Mayo ,Nicholas Kadysh ,Health Canada Special Access Program ,University Of Calgary ,Parker Psychedelics Research ,Veterans Affairs Canada ,Health Canada ,Senate Of Canada Subcommittee On Veterans ,Access Program ,Regulation Services Provider ,Senior Communications Specialist Kelly Johnston ,Pharmala Biotech Holdings Inc ,Neither The Canadian Securities Exchange ,Twitter ,Cannabinoid Therapeutics Lab Research Coordinator ,Parker Research ,Ala Biotech Holdings ,Heroic Hearts Canada ,Ethics Board Approval ,Observational Trial ,Special Access Program ,Ala Biotech ,Parker Research Chair ,Hearts Project Canada ,Post Traumatic Stress Disorder ,Real World Evidence ,Veterans Affairs ,Review Ethics Board ,Ethics Review Board ,Special Access ,Heroic Hearts ,Parker Psychedelics Research Chair ,Hearts Canada ,Executive Director ,Kaitlino Grady ,Canadian Securities Exchange ,Canadian Stock Exchange Mdma Cn ,Pharmala Biotech ,Clinical Trials ,Dma ,Authorized Prescriber ,A ,Psychedelics ,Ptsd ,Veterans ,